K. Landschulz

发表

Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat.

A. Rigotti, H. Hobbs, Ravindra Kumar Pathak, 1996, The Journal of clinical investigation.

Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes.

Richard T. Lee, Johnf . Thompson, G. D. De Keulenaer, 2002, American journal of physiology. Heart and circulatory physiology.

Aminopyrrolidineamide inhibitors of site-1 protease.

B. Hay, J. Hawkins, A. Varghese, 2007, Bioorganic & medicinal chemistry letters.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor (cid:1) Agonists with Robust Hypolipidemic Activity in Vivo □ S

P. Zagouras, O. Francone, L. Royer, 2009 .

Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile.

Haiyan Xu, R. Gimeno, C. Collins, 2006, Biochemical and biophysical research communications.

Pharmacologic Inhibition of Site 1 Protease Activity Inhibits Sterol Regulatory Element-Binding Protein Processing and Reduces Lipogenic Enzyme Gene Expression and Lipid Synthesis in Cultured Cells and Experimental Animals

I. Wang, B. Hay, K. Geoghegan, 2008, Journal of Pharmacology and Experimental Therapeutics.

Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

Helen H. Hobbs, Shangzhe Xu, A. Rigotti, 1996, Science.

Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle.

H. Hobbs, K. Wyne, Y. Ho, 1994, The Journal of biological chemistry.

Monocarboxylate transporter expression in mouse brain.

S. Vannucci, I. Simpson, W. Landschulz, 1998, The American journal of physiology.

Monocarboxylate transporter expression in mouse brain.

S. Vannucci, I. Simpson, W. Landschulz, 1998, American journal of physiology. Endocrinology and metabolism.

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

H. Hobbs, V. Mooser, M. Abedin, 1996, The Journal of clinical investigation.

Biomarkers of the Hedgehog/Smoothened pathway in healthy volunteers.

S. Stepaniants, L. Brail, J. Brandt, 2012, American journal of translational research.

Delivery of RNAi reagents in murine models of obesity and diabetes

E. Bush, P. Jung, C. Rondinone, 2006, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.

Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia

L. Munsie, C. Ruble, B. Kinon, 2010, The Pharmacogenomics Journal.

Genetic factors that contribute to interindividual variations in plasma low density lipoprotein-cholesterol levels.

H. Hobbs, A. Gaw, R. Barnes, 1996, Ciba Foundation symposium.

Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor γ Coactivator 1β and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese Mice*

E. Bush, P. Jung, C. Rondinone, 2007, Journal of Biological Chemistry.

Mechanical Strain Induces Specific Changes in the Synthesis and Organization of Proteoglycans by Vascular Smooth Muscle Cells*

Richard T. Lee, P. Libby, Johnf . Thompson, 2001, The Journal of Biological Chemistry.

Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.

Haiyan Xu, Harriet T. Smith, R. Reilly, 2007, Frontiers in bioscience : a journal and virtual library.

Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo

P. Zagouras, O. Francone, L. Royer, 2009, Molecular Pharmacology.